<DOC>
	<DOC>NCT02147561</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of BOTOX® treatment in Korean adults with chronic migraine.</brief_summary>
	<brief_title>A Safety and Efficacy Study of BOTOX® in Korean Adults With Chronic Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Ethnically Korean with a diagnosis of chronic migraine Anticipated need for botulinum toxin treatment for any reason other than chronic migraine during the study Diagnosis of myasthenia gravis, EatonLambert syndrome, or amyotrophic lateral sclerosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>